帕金森病的负担基于GBD 2021年
Huiqun Yang1,2, Liyuan Pu1,2, Tian Zhao1,2
1Department of Clinical Epidemiology, Ningbo 2 Hospital, Ningbo, Zhejiang, China.
International journal of public health
|March 12, 2026
概括
全球帕金森病 (PD) 病例在1992年至2021年间增加了三倍以上,这主要是由于人口增长. 年龄标准化率也增加,突显了针对性预防策略的必要性.
科学领域:
- 神经学 神经学
- 流行病学 流行病学
- 公共卫生 公共卫生
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,其全球流行率正在增加.
- 了解时间趋势对于制定有效的公共卫生干预措施至关重要.
研究的目的:
- 分析1992年至2021年帕金森病患病率的全球时间趋势.
- 确定PD负担变化的关键驱动因素.
- 为了告知有针对性的预防和控制策略.
主要方法:
- 利用了2021年全球疾病负担研究的数据.
- 采用一个年龄时期的队列模型来评估时间趋势.
- 进行了分解分析,以评估人口影响.
主要成果:
- 全球PD病例从340多万增加到近1180万 (1992-2021).
- 年龄标准化的PD患病率从每10万人口中的191.38增加到292.93.
- 人口增长被确定为PD负担增加的主要驱动因素.
结论:
- 全球和区域的PD患病率和年龄标准化率有所增加,特别是在60岁以上的人群中.
- 区域特定的战略是必要的,以与全球卫生目标保持一致.
- 这些发现强调了对帕金森病采取主动公共卫生措施的迫切需要.
相关概念视频
Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Neural Regulation
44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
285
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
285
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K


